ELI LILLY & Co

For the period ended Sep 30, 2024. Filed Oct 30, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 30, 2024

LLY$1,432.29+1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Condensed Statements of Shareholders' Equity

	Equity of Eli Lilly and Company Shareholders
(Dollars in millions, except per-share data, and shares in thousands) · Common Stock · AdditionalPaid-inCapital · RetainedEarnings · Employee Benefit Trust · Accumulated Other Comprehensive Loss · Common Stock in Treasury(1) · Noncontrolling Interests
Shares · Amount · Shares · Amount
Balance at July 1, 2023	949,688	$593.6			$6,948.6		$10,368.5		$(3,013.2)	$(3,788.7)		402	$(45.0)	$85.5
Net income (loss)					(57.4)						4.1
Other comprehensive income, net of tax								3.8
Issuance of stock under employee stock plans, net	17			(4.2)
Stock-based compensation			215.6
Other					(1.2)						(2.6)
Balance at September 30, 2023	949,705	$593.6			$7,160.0		$10,309.9		$(3,013.2)	$(3,784.9)		402	$(45.0)	$87.0
Balance at July 1, 2024	950,781	$594.2			$7,214.2		$13,178.0		$(3,013.2)	$(4,378.5)		365	$(32.7)	$73.5
Net income					970.3						11.8
Other comprehensive income, net of tax								103.7
Retirement of treasury shares	(582)	(0.3)				(520.8)				(582)		521.1
Purchase of treasury shares									582	(521.1)
Issuance of stock under employee stock plans, net	16			(7.8)
Stock-based compensation			133.2
Other					(0.3)						(4.6)
Balance at September 30, 2024	950,215	$593.9			$7,339.6		$13,627.2		$(3,013.2)	$(4,274.8)		365	$(32.7)	$80.7

(1) As of September 30, 2024, there was $1.98 billion remaining under our $5.00 billion share repurchase program authorized in May 2021.

	Equity of Eli Lilly and Company Shareholders
(Dollars in millions, except per-share data, and shares in thousands) · Common Stock · AdditionalPaid-inCapital · RetainedEarnings · Employee Benefit Trust · Accumulated Other Comprehensive Loss · Common Stock in Treasury(1) · Noncontrolling Interests
Shares · Amount · Shares · Amount
Balance at January 1, 2023	950,632	$594.1		$6,921.4		$10,042.6		$(3,013.2)	$(3,844.6)		450	$(50.5)	$125.6
Net income				3,050.7						4.6
Other comprehensive income, net of tax							59.7
Cash dividends declared per share: $2.26				(2,034.0)
Retirement of treasury shares	(2,299)	(1.4)			(748.6)				(2,299)		750.0
Purchase of treasury shares								2,299	(750.0)
Issuance of stock under employee stock plans, net	1,372	0.9		(269.7)					(48)		8.8
Stock-based compensation			508.3
Other				(0.8)					(3.3)		(43.2)
Balance at September 30, 2023	949,705	$593.6		$7,160.0		$10,309.9		$(3,013.2)	$(3,784.9)		402	$(45.0)	$87.0
Balance at January 1, 2024	949,781	$593.6		$7,250.4		$10,312.3		$(3,013.2)	$(4,327.0)		402	$(44.2)	$91.8
Net income (loss)				6,180.2						(3.2)
Other comprehensive income, net of tax							52.2
Cash dividends declared per share: $2.60				(2,342.9)
Retirement of treasury shares	(582)	(0.3)			(520.8)				(582)		521.1
Purchase of treasury shares								582	(521.1)
Issuance of stock under employee stock plans, net	1,016	0.6		(414.5)					(37)		11.5
Stock-based compensation			503.7
Other				(1.6)						(7.9)
Balance at September 30, 2024	950,215	$593.9		$7,339.6		$13,627.2		$(3,013.2)	$(4,274.8)		365	$(32.7)	$80.7

(1) As of September 30, 2024, there was $1.98 billion remaining under our $5.00 billion share repurchase program authorized in May 2021.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.